Preclinical studies have demonstrated the efficacy and safety of CT-P44 in various tumor models. In a study published in the Journal of Clinical Oncology, researchers showed that CT-P44:
is an investigational drug candidate developed by Celltrion . Based on publicly available information:
Preclinical studies have demonstrated the efficacy and safety of CT-P44 in various tumor models. In a study published in the Journal of Clinical Oncology, researchers showed that CT-P44:
is an investigational drug candidate developed by Celltrion . Based on publicly available information: ct-p44